21 May 2009
Urinary tract infections (UTI’s) in the early post-transplant period after simultaneous pancreas-kidney transplantation
D Kawecki, A Kwiatkowski, G Michalak, A Sawicka-Grzelak, A Mlynarczyk, B Sokol-Leszczynska, I Serafin, J Czerwinski, W Lisik, M Bieniasz, M Wszola, P Domagala, W Rowinski, M Durlik, M Luczak, A Chmura, G MlynarczykAnn Transplant 2009; 14(1): 70-70 :: ID: 880457
Abstract
Background: Urinary Tract Infection (UTI) is a one of the common infections in the simultaneous pancreas-kidney transplantation (SPKTX).
Material/Methods: The study covered 26 adult patients undergoing SPKTX
transplantation between September 2001 and December 2006. All the patients were followed prospectively for urinary tract infections from the SPKTX date and during the first four weeks after the surgery. Samples of urine were investigated for bacteriological cultures. The microorganisms were cultured and identified in accordance with standard bacteriological procedures. Susceptibility testing was carried out using Clinical and Laboratory Standards Institute (CLSI) procedures.
Results: Urine specimens were examined in 26 recipients (100%) during the first month after transplantation, 77 urine samples were investigated. Among the bacterial strains isolated in the early period after SPKTX (n = 30), the most common were Gram-positive bacteria (53.3%) with domination of enterococci (75%) with presence of high level aminoglycoside resistant strains - HLAR (58.3%) and vancomycin resistant strains - VRE (25%). Gram-negative bacteria comprised (46.7%) of positive cultures.
Conclusions: In our study dominated entrococci comprising 75% of Gram(+)
isolates. The increased proportion of isolation MDR bacteria to antimicrobial agents may be due to the frequent use of these agents for prophylaxis of bacterial infections in patients. MDR strains can cause severe UTI's in patients after SPKTX.
Keywords: Pancreas Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






